IL15RA and neoplasm: IL15Rα-IL15-armed OVs, in conjunction with ACT, rapamycin, and celecoxib provide potent antitumor effects against brain tumors, suggesting that complex but rationally designed therapeutic combinations can produce robust anti-tumor effects.